Biospectal Selected as One of Ten Finalists for the “Saving Lives at Birth” 2018 Grand Challenge
Biospectal was recently selected from more than five hundred applicants to present with our partner team at the Saving Lives at Birth Global Grand Challenge DEVELOPMENTxCHANGE conference in Washington, D.C. Saving Lives at Birth is focused on identifying and scaling transformative prevention and treatment approaches for pregnant women and newborns. It brings together the U.S. Agency for
Biospectal to Present the Democratized Future of Biosensing at Digital Health Connect ’18
On June 15, Professor Patrick Schoettker M.D., co-founder, Senior Medical Advisor, and inspiration behind Biospectal’s breakthrough software based optical analysis in smartphones to tackle the global hypertension epidemic, will present at the Digital Health Connect conference sponsored by Swiss Digital Health His topic, “Optical Vital Signs Monitoring, the Future of Today,” explores the exciting health potential of advances
Biospectal One of Six Swiss Startups at CES 2018
Biospectal was honored to be chosen as one of six Swiss startups representing the next generation of Swiss innovation at this year’s CES in Las Vegas. Dr. Patrick Schoettker was blown away by the interest in optical biosensing and Biospectal’s smartphone app solution for monitoring blood pressure through the fingertip.”We know that 1.7 Billion people